Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
Where Will Pfizer Be in 5 Years?
Pfizer is working hard to deal with some big headwinds it has coming up, but in five years, this should all be in the past.
2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now
Ongoing developments make these companies look attractive.
Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?
A new deal with the White House could lead to a new sales channel that bypasses health insurance companies.
Dogs of the Dow
Wilsey Discloses $2.9 Million Purchase of Pfizer Stock Amid Landmark Trump Deal
Down 50%, Should You Buy the Dip on Pfizer?
Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
Tariffs aren't likely to weigh on growth at these companies.
Great News for Pfizer Stock Investors
Pharma stocks have been under pressure from the administration in 2025.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q4 2024 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2024.
Pfizer (PFE) Q3 2024 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2024.
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024.
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.